Cambridge University Press 978-1-107-48069-8 - Gynaecology: Evidence-Based Algorithms Jyotsna Pundir and Arri Coomarasamy Index More information INDEX abdominal sacrocolpopexy 132, 133, 136 pregnancy and 248 prevalence 214 acne 276 sexual partners 248 recurrent 213, 215 acromegaly 81 anorexia 71 treatment 215 actinomyces-like organisms 168 anovulation management, polycystic ovarian sexual partners 215 acupuncture/acupressure syndrome 83, 84, 85 Baden–Walker System for prolapse dysmenorrhoea 29 anti-D immunoglobulin prophylaxis evaluation 130 hyperemesis gravidarum 26, 24 miscarriage 7, 4 Beçhet’s disease, vulval 156 menopausal symptoms 145 molar pregnancy 16 behavioural interventions adenomyomectomy 52 antimüllerian hormone (AMH) 62 dysmenorrhoea 29 adenomyosis 50 antiandrogens, hirsutism 89 overactive bladder 127 clinical features 50 antibiotics premenstrual syndrome 32 differential diagnosis 29 bacterial vaginosis 215 beta blockers, menopausal symptoms 144 infertility relationship 53 chancroid 236 bilateral salpingo-oophorectomy (BSO) management 53 chlamydia 227 endometrial cancer 177 investigations 50 Donovanosis 238 endometriosis 57 management 51 entry into breast milk 215 heavy menstrual bleeding 41 medical 51 gonorrhoea 225 ovarian cancer and 185, 191, 192 surgical 52 lymphogranuloma venereum 232 premenstrual syndrome 33 prevalence 50 pelvic inflammatory disease 207, 208 biofeedback, urinary incontinence 124 adhesiolysis prophylaxis, pregnancy termination 8 biopsy chronic pelvic pain 202 syphilis 243, 244 ano-genital warts 247 infertility management 103 antidepressants, chronic pelvic pain 202 cervical intra-epithelial neoplasia 166 endometriosis-related 58 antihistamines, hyperemesis gravidarum 25 cone biopsy 15 adhesions 202 antimuscarinic drugs, overactive bladder 127 disorder of sex development 62 investigation 103 antiphospholipid syndrome (APS) 13 endometrial hyperplasia 173 see also adhesiolysis management 14 myometrial 50 adnexal masses, differential diagnosis 183 screening 12 post-menopausal bleeding 180 adnexal torsion 114 antispasmodics, inflammatory bowel vulval 151, 159 alcohol consumption in pregnancy, syndrome 204 black cohosh, menopausal symptoms 145 miscarriage risk 12 anti-thyroid antibodies, miscarriage risk bladder catheterization 123 alpha fetoprotein (AFP), ovarian cancer 13, 15 bladder diaries 121 assessment 189 antiviral therapy bladder scan 121 ambiguous genitalia herpes 229 bladder training 127 differential diagnosis 63 molluscum contagiosum 233 bleeding in early pregnancy investigations 62 aromatase deficiency, placental 66 differential diagnosis 2, 19 see also disorders of sex development aromatase inhibitors investigations 3 ambulatory urodynamics 122 adenomyosis 51 see also miscarriage amenorrhoea fibroid 45 bleeding patterns with hormonal primary 69 polycystic ovarian syndrome 84 contraceptives complications 69 precocious puberty 99 alterations 276 examination 69 ascites, ovarian hyperstimulation expected patterns 272 history 69 syndrome 112, 114 unscheduled bleeding 272 investigations 69 aspiration, ovarian cyst 185, 186 examination 272 secondary 72 aspirin history 272 examination 72 endometrial cancer risk reduction 175 investigations 272 history 72 miscarriage prevention 14, 15 management 273 investigations 62 assisted reproduction 59 bone age, precocious puberty Amsel criteria for bacterial vaginosis 214 long-term safety 105 investigation 97, 98 analgesics premature ovarian failure and 76 bone health 276 chronic pelvic pain 201 virology issues 105 combined hormonal contraceptive endometriosis 55 see also fertility problems; specific effects 278 anastrozole, polycystic ovarian syndrome 84 techniques progestogen-only contraception androgen excess, polycystic ovarian augmentation cystoplasty 128 impact 255, 279 syndrome 80 autoimmune oophoritis 74 women aged over 40 years 278–9 androgen insensitivity 67, 71 azoles, candidiasis 216, 217 Bonney test 122 androgen-secreting tumours 81 botulinum toxin, detrusor overactivity 128 hirsutism and 86 bacterial vaginosis (BV) 212, 214 brachytherapy, endometrial cancer 177 precocious puberty and 96 complications 214 breast cancer ano-genital warts 247 diagnosis 210, 211, 214 BRCA1/BCRA2 mutations 198, 254 clinical features 247 history 214 prophylactic surgery 198 differential diagnosis 247 in pregnancy 213, 214, 215 combined hormonal contraception risk 254 management 248 miscarriage risk 13, 14 HRT risk 141 follow-up 248 termination and 215 breastfeeding see lactation 301 © in this web service Cambridge University Press www.cambridge.org Cambridge University Press 978-1-107-48069-8 - Gynaecology: Evidence-Based Algorithms Jyotsna Pundir and Arri Coomarasamy Index More information bromocriptine 92 cetirizine, candidiasis 217 expected bleeding patterns 272 hyperprolactinaemia 92 chancre 242 non-contraceptive benefits 253 safety in pregnancy 94 see also syphilis postnatal contraception 283, 298 buboes chancroid 223, 235 risks and side effects 254 chancroid 235 clinical features 235 unscheduled bleeding management 273 lymphogranuloma venereum 232 differential diagnosis 235 women aged over 40 years 278 management 232, 236 investigations 235 combined oral contraceptives (COCs) 37 management 236 adenomyosis management 51 CA125 levels 150, 184 follow-up 236 chronic pelvic pain management 201 endometriosis investigation 55 chemotherapy commencement 253 ovarian cancer 188, 189 cervical cancer 171 continuous and extended use treatment response evaluation 194 endometrial cancer 177, 178 (CECOC) 293 cabergoline 92 ovarian cancer 191, 192 dysmenorrhoea management 30 hyperprolactinaemia 92 first line 193 endometrial cancer risk reduction 175 safety in pregnancy 94 germ cell tumors 197 endometriosis management 56 caffeine reduction, overactive bladder 123 second line 194 fibroid management 45 calcitonin, endometriosis 56 sex cord stromal tumors 197 heavy menstrual bleeding management 36 cancer vulval cancer 162 hirsutism management 88 epidemiology 148 chlamydia 222, 226 interstitial cystitis management 203 gynaecological cancers 149 clinical features 226 missed pill 274, 286 fertility sparing treatments 115 complications 226 ovarian cyst and 186 mortality causes 148 investigations 226 pelvic inflammatory disease and 208 referral recommendations 150 management 227 premature menopause management 76 risk with polycystic ovarian syndrome 82 in pregnancy and lactation 227 premenstrual syndrome management 32 see also specific types of cancer sexual partners 227 venous thromboembolism risk 276, 297 candidiasis see vulvo-vaginal candidiasis pelvic inflammatory disease 207 see also combined hormonal contraception cardiolipin tests, syphilis 243 prevalence 226 combined vaginal ring (CVR) 253, 297 cardiovascular risk sample sites 226 complementary therapies HRT effects 140 screening 103 dysmenorrhoea 29 polycystic ovarian syndrome see also lymphogranuloma venereum endometriosis 57 relationship 82 chromosomal anomalies menopausal symptoms 145 progestogen-only contraception 255 male infertility 108 premenstrual syndrome 33 women aged over 40 years 278 recurrent miscarriage risk 13 urinary incontinence 123 cervical cancer 169 chronic pelvic pain 200 complete androgen insensitivity (CAIS) 67 examination 169 definition 200 computed tomography (CT) management 171 differential diagnosis 200 ovarian cyst 184 fertility sparing treatments 15, 116 examination 200 pituitary imaging 91 follow-up 172 history 200 condoms 251 in pregnancy 172 interstitial cystitis 203 counselling regarding correct use 251 prevalence 169 investigations 201 female 248, 252 referral to colposcopy 169 irritable bowel syndrome 204 postnatal contraception 283 risk factors 169 management 201, 202 STI prevention 248, 251 combined hormonal contraception 254 evidence round-up 205 ano-genital warts 248 progestogen-only contraception 255 service provision 200 condylomata acuminata see ano-genital warts staging 169, 170 what not to do 205 cone biopsy 15 cervical cap 252 ‘red flag’ symptoms 201 congenital adrenal hyperplasia (CAH) 60 correct use 252 referral 201 hirsutism 86 postnatal contraception 283 cidofovir, vulval intra-epithelial neoplasia 152 late-onset 81 cervical cerclage 14 clindamycin management 66, 99 cervical intra-epithelial neoplasia (CIN) 164 bacterial vaginosis 13, 215 see also disorders of sex development ablative techniques 166 entry into breast milk 215 congenital bilateral absence of the vas deferens biopsy 166 clobetasol propionate, lichen sclerosus 154 (CBAVD) 108 colposcopy referral 165 clomiphene citrate 84 congenital syphilis 242 cytological findings 165 polycystic ovarian syndrome 84 management 245 examination 165 clonidine, menopausal symptoms 144 screening 245 follow-up 167 codeine, dysmenorrhoea 30 consent issues histology findings 167 cognitive behavioural therapy (CBT), laparoscopy 205 hysterectomy and 168 premenstrual syndrome 32 sterilization 294 pathogenesis 164 cognitive benefits of HRT 140 surgical management of miscarriage 7 repeat excision 167 colorectal cancer risk utero-vaginal prolapse surgery 134 screening 164 combined oral contraception benefits 253 constipation 204 cervical mucus, post-coital testing 103 HRT benefits 140 constitutional delay 71 cervical screening 164, 168 colpocleisis 132, 137 contraception age of referral 164 colporrhaphy drug interactions 268 cervical stenosis anterior 132 ectopic pregnancy and 23 cervical screening and 168 posterior 132 failure rates 261 differential diagnosis 29 colposcopy 165 female barrier methods 252 cervical weakness, recurrent miscarriage